STAT3 and neoplasm: To further examine whether blockade of STAT3 signaling can decrease tumor progression by rescuing the Th17-induced inhibition of CD8+ T cell infiltration in tumor tissues, Stattic was administered by intraperitoneal injection to Luc-GFP-HCT116-tumor bearing mice (Fig. 6d).